Molecular profiling of the residual tumor of ovarian cancer after neoadjuvant chemotherapy
Molecular profiling of the residual tumor of ovarian cancer after neoadjuvant chemotherapy
批准号:
20K18180
负责人:
EBATA TAKAHIRO
金额:
$2.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Early-Career Scientists
财政年份:
2020
资助国家:
日本
项目状态:
已结题
起止时间:
2020-04-01 至 2023-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DNA methylation marker to estimate cancer cell fraction
用于估计癌细胞分数的 DNA 甲基化标记
DOI:
--
发表时间:
2021
期刊:
影响因子:
--
作者:
[Yuka Okazaki, Kosuke Taniguchi, Yoshitaka Miyamoto, Kazuhiko Nakabayashi, Kayoko Kaneko, Hiromi Hamada, Toyomi Satoh, Atsuko Murashima, Kenichiro Hata, Ebata Takahiro]
通讯作者:
Ebata Takahiro
Identification of Enhancer Methylation Associated with Treatment Resistance of Ovarian Cancer after Neoadjuvant Chemotherapy
与新辅助化疗后卵巢癌治疗耐药相关的增强子甲基化的鉴定
DOI:
--
发表时间:
2020
期刊:
影响因子:
--
作者:
[Yuka Okazaki , Kosuke Taniguchi , Yoshitaka Miyamoto , Kazuhiko Nakabayashi , Kayoko Kaneko , Hiromi Hamada , Toyomi Satoh , Atsuko Murashima , Kenichiro Hata, 江畑貴大]
通讯作者:
江畑貴大
DNA methylation of the immediate upstream region of BRCA1 major transcription start sites is an independent favorable prognostic factor in patients with high-grade serous ovarian cancer
BRCA1主要转录起始位点直接上游区域的DNA甲基化是高级别浆液性卵巢癌患者的独立有利预后因素
DOI:
10.1016/j.ygyno.2022.10.008
发表时间:
2022
期刊:
Gynecologic Oncology
影响因子:
4.7
作者:
[Ebata Takahiro, Yamashita Satoshi, Takeshima Hideyuki, Yoshida Hiroshi, Kawata Yoshiko, Kino Nao, Yasugi Toshiharu, Terao Yasuhisa, Yonemori Kan, Kato Tomoyasu, Ushijima Toshikazu]
通讯作者:
Ushijima Toshikazu
DNA methylation marker to estimate ovarian cancer cell fraction
用于估计卵巢癌细胞分数的 DNA 甲基化标记
DOI:
10.1007/s12032-022-01679-y
发表时间:
2022
期刊:
Medical Oncology
影响因子:
3.4
作者:
[Ebata Takahiro, Yamashita Satoshi, Takeshima Hideyuki, Yoshida Hiroshi, Kawata Yoshiko, Kino Nao, Yasugi Toshiharu, Terao Yasuhisa, Yonemori Kan, Kato Tomoyasu, Ushijima Toshikazu]
通讯作者:
Ushijima Toshikazu
海外基金